Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiling Zhang

Showing results (121-130 of 216) with videos related to

Pageof 22
Sort By:
Frontiers in Pharmacology|April 10, 2023
Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and <i>vitro</i> assayLexian Chen, Qianqian Lv, Jianghong Cai, et al.
Radiation Oncology (London, England)|November 3, 2021
Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinomaYang Liu, Zhiling Zhang, Ruiqi Liu, et al.
Aging Cell|March 5, 2026
The Immune Cell Atlas of "Longevity Molecular Tag": Identification of Principal Immune Cell Subsets and Their Underlying Molecular Regulatory MechanismsZhiling Zhang, Huabin Su, Shihui Fu, et al.
European Urology|May 28, 2015
Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration RateBrian R Lane, Sevag Demirjian, Ithaar H Derweesh, et al.
The Journal of Urology|September 30, 2015
Surgical Salvage of Thermal Ablation Failures for Renal Cell CarcinomaJuan A Jiménez, Zhiling Zhang, Juping Zhao, et al.
Cancer Communications (London, England)|April 20, 2019
An improved ileal conduit surgery for bladder cancer with fewer complicationsZhiyong Li, Zhuowei Liu, Kai Yao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 24, 2025
Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinomaLingling Cai, Kaicong Chen, Qiwen Pan, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
First-line PD-1 blockades combined with TKIs for metastatic non-clear cell renal cell carcinoma: a real-world multicenter retrospective studyXi Zhong, Tingxuan Huang, Yulu Peng, et al.
Translational Andrology and Urology|April 11, 2022
Immune checkpoint inhibitors further aggravate proteinuria in patients with metastatic renal cell carcinoma after long-term targeted therapyKang Ning, Zeshen Wu, Xiangpeng Zou, et al.
European Urology Focus|July 21, 2017
Proteinuria in Patients Undergoing Renal Cancer Surgery: Impact on Overall Survival and Stability of Renal FunctionZhiling Zhang, Juping Zhao, Joseph Zabell, et al.
Pageof 22

Showing results (121-130 of 216) with videos related to

Sort By:
Pageof 22
Frontiers in Pharmacology|April 10, 2023
Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and <i>vitro</i> assayLexian Chen, Qianqian Lv, Jianghong Cai, et al.
Radiation Oncology (London, England)|November 3, 2021
Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinomaYang Liu, Zhiling Zhang, Ruiqi Liu, et al.
Aging Cell|March 5, 2026
The Immune Cell Atlas of "Longevity Molecular Tag": Identification of Principal Immune Cell Subsets and Their Underlying Molecular Regulatory MechanismsZhiling Zhang, Huabin Su, Shihui Fu, et al.
European Urology|May 28, 2015
Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration RateBrian R Lane, Sevag Demirjian, Ithaar H Derweesh, et al.
The Journal of Urology|September 30, 2015
Surgical Salvage of Thermal Ablation Failures for Renal Cell CarcinomaJuan A Jiménez, Zhiling Zhang, Juping Zhao, et al.
Cancer Communications (London, England)|April 20, 2019
An improved ileal conduit surgery for bladder cancer with fewer complicationsZhiyong Li, Zhuowei Liu, Kai Yao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 24, 2025
Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinomaLingling Cai, Kaicong Chen, Qiwen Pan, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
First-line PD-1 blockades combined with TKIs for metastatic non-clear cell renal cell carcinoma: a real-world multicenter retrospective studyXi Zhong, Tingxuan Huang, Yulu Peng, et al.
Translational Andrology and Urology|April 11, 2022
Immune checkpoint inhibitors further aggravate proteinuria in patients with metastatic renal cell carcinoma after long-term targeted therapyKang Ning, Zeshen Wu, Xiangpeng Zou, et al.
European Urology Focus|July 21, 2017
Proteinuria in Patients Undergoing Renal Cancer Surgery: Impact on Overall Survival and Stability of Renal FunctionZhiling Zhang, Juping Zhao, Joseph Zabell, et al.
Pageof 22